心脏淀粉样变性十年进展:病理生理学、诊断与定量、预后、治疗策略及疗效监测的认识进展
心脏淀粉样变性以淀粉样纤维沉积于心肌细胞外间隙为特征,多模态心脏影像可准确诊断并促进疾病修饰治疗启动。影像进展加深了对发病机制的理解、改善了预后评估,并衍生出反映淀粉样负荷的影像标志物,对评估治疗反应日益重要。传统治疗聚焦减少淀粉样蛋白形成与稳定病情,新药旨在加速免疫介导的心脏淀粉样纤维清除,追踪淀粉样负荷随时间变化至关重要;先进影像技术已显示追踪治疗反应的效力,未来人工智能可能提高精度并更早检出变化。
要点
- 多模态心脏影像可准确诊断心脏淀粉样变性并促进疾病修饰治疗及时启动。
- 影像标志物可反映淀粉样负荷,对评估治疗反应日益重要。
- 先进影像技术已显示追踪治疗反应的效力。
核心结论
- 多模态心脏影像的进展加深了对心脏淀粉样变性发病机制的理解、改善了预后评估,并衍生出反映淀粉样负荷的影像标志物,对评估治疗反应日益重要;先进影像技术已显示追踪治疗反应的效力,未来人工智能可能提高精度并更早检出治疗中的变化。
研究设计与样本
- 综述;阐述多模态心脏影像在心脏淀粉样变性病理生理学、诊断与定量、预后、治疗策略及疗效监测方面的进展。
临床应用与阅片要点
- 多模态心脏影像用于准确诊断心脏淀粉样变性并促进疾病修饰治疗及时启动。
- 影像标志物反映淀粉样负荷,用于评估治疗反应并追踪其随时间的变化。
- 先进影像技术已显示追踪治疗反应的效力。
- 作者认为未来人工智能可能提高精度并更早检出治疗中的变化。
局限性
- 未来需聚焦通过人工智能提高精度,可能增强治疗早期变化的检出。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Cardiac amyloidosis represents a unique disease process characterized by amyloid fibril deposition within the myocardial extracellular space. Advances in multimodality cardiac imaging enable accurate diagnosis and facilitate prompt initiation of disease-modifying therapies. Furthermore, rapid advances in multimodality imaging have enriched understanding of the underlying pathogenesis, enhanced prognostication, and resulted in the development of imaging-based markers that reflect the amyloid burden, which is of increasing importance when assessing the response to treatment. Whereas conventional therapies have focused on reducing amyloid formation and subsequent stabilization of the cardiac disease process, novel agents are being developed to accelerate the immune-mediated removal of amyloid fibrils from the heart. In this context, the ability to track changes in the amyloid burden over time is of paramount importance. Although advanced imaging techniques have shown efficacy in tracking the treatment response, future research focused on improved precision through use of artificial intelligence may augment the detection of changes earlier in the course of treatment.
引用
- Fontana M, Ioannou A, Cuddy S, et al. The Last Decade in Cardiac Amyloidosis: Advances in Understanding Pathophysiology, Diagnosis and Quantification, Prognosis, Treatment Strategies, and Monitoring Response. JACC Cardiovasc Imaging. 2025. PMID: 39797879. doi:10.1016/j.jcmg.2024.10.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。